Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

We can be heroes

Is collaboration key?

- PMLiVE

FDA starts review of Sanofi’s oral type 1 diabetes drug

The US regulator has started its review of Sanofi and Lexicon Pharma’s sotagliflozin for type 1 diabetes, which the firms say could have blockbuster potential.Sotagliflozin – which has the proposed...

Is the pharma business model ready for precision medicine?

Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Blue Latitude Health

- PMLiVE

Porterhouse Medical announces another well-deserved promotion within the group

It is with great pleasure that Porterhouse Medical announces that Amanda Lyons has been promoted to senior account director, working across European and UK teams in scientific and medical communications....

Porterhouse Medical Group

- PMLiVE

FDA clears Dova drug for liver-related low blood platelets

Drug is in the same class as Novartis’ Promacta/Revolade

- PMLiVE

Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more

A rapid round up from the frontline of pharma, biotech and healthcare

- PMLiVE

Porterhouse Medical promotes Amanda Lyons

She becomes the agency’s senior account director

Dr Martin Rothman joins Sofinnova Partners

He becomes the firm’s venture partner

The NHS and ABPI at 70: inching closer to the triple win

The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...

Health Unlimited welcomes Ann Bartling in significant new PR hire

Monday 21 May, London: Global health consultancy and communications agency Health Unlimited has added to its senior talent in London with the hire of Ann Bartling as PR Practice Lead....

Health Unlimited

- PMLiVE

More encouraging data for Spark and Pfizer’s potential haemophilia B cure

Pfizer set to commence phase III trials

- PMLiVE

Positive mid-stage trial gives Allergy’s investors some welcome relief

Its grass pollen vaccine showed a “highly significant” dose response

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links